These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8406384)

  • 1. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
    de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
    Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features.
    Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC
    Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M; Berti E; Rosso R; Boveri E; Kindl S; Klersy C; Lazzarino M; Borroni G; Menestrina F; Santucci M
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
    Magro CM; Momtahen S; Kiuru M
    Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
    J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
    Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
    Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
    Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
    J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL; de Bruin PC; Oudejans JJ; Ossenkoppele GJ; van der Valk P; Meijer CJ
    Histopathology; 2003 Nov; 43(5):462-9. PubMed ID: 14636272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A primary systemic ALCL present initially as cutaneous localized skin lesions: report of an unusual case.
    ALSayyah A; AlHumidi A
    Am J Dermatopathol; 2015 Jan; 37(1):e12-4. PubMed ID: 24752216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.
    ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Meijer CJ
    J Pathol; 2003 May; 200(1):4-15. PubMed ID: 12692835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma.
    Asano N; Suzuki R; Ohshima K; Kagami Y; Ishida F; Yoshino T; Ogawa H; Morishima Y; Nakamura S
    Int J Hematol; 2010 Apr; 91(3):426-35. PubMed ID: 20217288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
    Magro CM; Dyrsen ME
    J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
    Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
    Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases.
    Yu BH; Zhang Y; Xue T; Shui RH; Lu HF; Zhou XY; Zhu XZ; Li XQ
    Diagn Pathol; 2021 Jan; 16(1):1. PubMed ID: 33402163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of the HECA-452 antigen (cutaneous lymphocyte associated antigen, CLA) in cutaneous and non-cutaneous T-cell lymphomas.
    Noorduyn LA; Beljaards RC; Pals ST; van Heerde P; Radaszkiewicz T; Willemze R; Meijer CJ
    Histopathology; 1992 Jul; 21(1):59-64. PubMed ID: 1634202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome.
    Tilly H; Gaulard P; Lepage E; Dumontet C; Diebold J; Plantier I; Berger F; Symann M; Petrella T; Lederlin P; Brière J
    Blood; 1997 Nov; 90(9):3727-34. PubMed ID: 9345059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
    Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
    J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.